Live Breaking News & Updates on நீரோடை பார்மா|Page 7
Stay updated with breaking news from நீரோடை பார்மா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Torrent Pharma share gains 6% post Q4 earnings- Business News origin-businesstoday.intoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from origin-businesstoday.intoday.in Daily Mail and Mail on Sunday newspapers.
: Wednesday, May 19, 2021, 12:26 AM IST Stocks to watch: Axis Bank, Panacea Biotec, Torrent Pharma, Ujjivan SFB, Abbott India, L&T, Canara Bank, Tata Motors others There are some stocks that may be much more active than others. So, some stocks to watch out for today are: Axis Bank: Specified Undertaking of the Unit Trust of India (SUUTI) is looking at selling 3.6 crore shares via offer for sale (OFS) in private lender Axis Bank at a floor price of Rs 680 per share. This will help the government raise up to Rs 3,949.34 crore. Panacea Biotec: Although Serum Institute of India (SII) CEO Adar Poonawalla on Monday offloaded his entire stake in Panacea Biotec amounting to 5.15 per cent shareholding of the firm, SII continues to hold 9.83 per cent stake in Panacea Biotec. The listed company informed the exchange that Poonawallaâs company SII through various holding and investing companies has a 9.83 per cent stake in Panacea Biotec. ....
3,375,243.0 On Monday US drug maker Eli Lilly said that it will issue voluntary licence to Hyderbad based Natco pharma, ending the legal battle that was brimming over compulsory license for the drug in less than a month. Natco will be collaborating with Lilly to further accelerate and expand the availability of baricitinib in India during this pandemic, improving the local treatment options available to positively impact the lives of people who are currently battling COVID-19 in India , the company said in a statement. Adding that the company continues to engage in active dialogue with the regulatory authorities and government in India to deliver baricitinib donations through the humanitarian aid organization, Direct Relief and to donate Lilly’s anti-COVID-19 treatments, including Lilly’s neutralizing antibodies. ....
Natco Pharma to further expedite the availability of baricitinib for COVID-19 patients in India. The company has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma and the Hyderabad-based company will be collaborating with Eli Lilly to further accelerate and expand the availability of baricitinib in India during this pandemic. The move will improve the local treatment options available and will positively impact the lives of people who are currently battling COVID-19 in India, Eli Lilly said in a statement. Earlier, the company had announced signing of six voluntary license agreements with Cipla, Lupin, Sun Pharmaceutical Industries, Dr Reddy s, MSN Laboratories and Torrent Pharmaceuticals. ....
Covid, Q4 earnings, vaccination among key factors that may guide market this week SECTIONS Share Synopsis Among Nifty stocks, Bharti Airtel, Tata Motors, Indian Oil Corporation, State Bank of India, Shree Cement, JSW Steel and Hindalco will announce the march quarter earnings. Nifty50 behaved in line with global indices and closed in the red on a weekly basis. The index failed to retest the immediate resistance zone of 15,000 as it is facing pressure at higher levels. Related NEW DELHI: The domestic equity market began the week on a high note, hoping that the pandemic will eventually peak out and the economy will recover sooner than expected. However, the euphoria fizzled out soon as investors turned wary of inflation in India and the US, with analysts expecting central banks to start tapering soon. Higher bond yields globally may result in further outflows. However, upbeat Q4 numbers provided some breather, but the action remained stock specific. ....